All Stories

  1. B cell-derived circulating granzyme B is a feature of acute infectious mononucleosis

    Article • Clinical & Translational Immunology, June 2015, Wiley

    Professor Rajiv Khanna

  2. Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction

    Article • Journal of Virology, June 2015, ASM Journals

    Professor Rajiv Khanna

  3. Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus–Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation

    Article • The Journal of Infectious Diseases, June 2015, Oxford University Press (OUP)

    Professor Rajiv Khanna

  4. Adoptive therapy for EBV-induced cancers: driving success with post-transplant lymphoproliferative disorder to other EBV-derived tumors

    Article • Immunotherapy, June 2015, Future Medicine

    Professor Rajiv Khanna

  5. Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation

    Article • Clinical & Translational Immunology, March 2015, Wiley

    Professor Rajiv Khanna

  6. Naive CD8 + T‐cell precursors display structured TCR repertoires and composite antigen‐driven selection dynamics

    Article • Immunology and Cell Biology, March 2015, Wiley

    Professor Rajiv Khanna

  7. Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor

    Article • European Journal of Medicinal Chemistry, March 2015, Elsevier

    Professor Rajiv Khanna

  8. Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement

    Article • Clinical & Translational Immunology, January 2015, Wiley

    Professor Rajiv Khanna

  9. Vaccination for cytomegalovirus: when, where and how

    Article • Microbiology Australia, January 2015, CSIRO Publishing

    Professor Rajiv Khanna

  10. The Development of Prophylactic and Therapeutic EBV Vaccines

    Article • January 2015, Springer Science + Business Media

    Professor Rajiv Khanna

  11. mRNA Structural Constraints on EBNA1 Synthesis Impact on In Vivo Antigen Presentation and Early Priming of CD8+ T Cells

    Article • PLoS Pathogens, October 2014, PLOS

    Professor Rajiv Khanna

  12. Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme

    Article • Frontiers in Oncology, October 2014, Frontiers

    Professor Rajiv Khanna

  13. Epstein–Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?

    Article • Immunotherapy, June 2014, Future Medicine

    Professor Rajiv Khanna

  14. Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment

    Article • OncoImmunology, June 2014, Taylor & Francis

    Professor Rajiv Khanna

  15. G-quadruplexes regulate Epstein-Barr virus–encoded nuclear antigen 1 mRNA translation

    Article • Nature Chemical Biology, March 2014, Springer Science + Business Media

    Professor Rajiv Khanna

  16. Molecular Imprint of Exposure to Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell Repertoire

    Article • Scientific Reports, February 2014, Springer Science + Business Media

    Professor Rajiv Khanna

  17. Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity

    Article • Human Vaccines & Immunotherapeutics, January 2014, Taylor & Francis

    Professor Rajiv Khanna

  18. Phenotypic and transcriptional profile correlates with functional plasticity of antigen‐specific CD4 + T cells

    Article • Immunology and Cell Biology, December 2013, Wiley

    Professor Rajiv Khanna

  19. Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications

    Article • PLoS ONE, October 2013, PLOS

    Professor Rajiv Khanna

  20. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases

    Article • Expert Review of Vaccines, June 2013, Taylor & Francis

    Professor Rajiv Khanna

  21. Epstein?Barr virus-associated malignancies: pathobiology and emerging therapeutic options

    Article • Microbiology Australia, January 2013, CSIRO Publishing

    Professor Rajiv Khanna

  22. Nasopharyngeal Carcinoma Immunotherapy: Current Strategies and Perspectives

    Article • January 2013, Springer Science + Business Media

    Professor Rajiv Khanna

  23. Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1

    Article • PLoS Pathogens, December 2012, PLOS

    Professor Rajiv Khanna

  24. Host immune system strikes back

    Article • Autophagy, December 2012, Taylor & Francis

    Professor Rajiv Khanna

  25. A new approach for cellular immunotherapy of nasopharyngeal carcinoma

    Article • OncoImmunology, November 2012, Taylor & Francis

    Professor Rajiv Khanna

  26. Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus‐specific T‐cells in patients with glioblastoma multiforme

    Article • Immunology and Cell Biology, April 2012, Wiley

    Professor Rajiv Khanna

  27. Molecular Pathogenesis of EBV Susceptibility in XLP as Revealed by Analysis of Female Carriers with Heterozygous Expression of SAP

    Article • PLoS Biology, November 2011, PLOS

    Professor Rajiv Khanna

  28. Human immunology: a case for the ascent of non‐furry immunology

    Article • Immunology and Cell Biology, March 2011, Wiley

    Professor Rajiv Khanna

  29. Understanding human T‐cell‐mediated immunoregulation through herpesviruses

    Article • Immunology and Cell Biology, February 2011, Wiley

    Professor Rajiv Khanna

  30. Herpesvirus vaccines: Challenges and future prospects

    Article • Human Vaccines, December 2010, Taylor & Francis

    Professor Rajiv Khanna

  31. Generation of Cytotoxic T Lymphocytes for Immunotherapy of EBV-Associated Malignancies

    Article • January 2010, Springer Science + Business Media

    Professor Rajiv Khanna

  32. Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases

    Article • Journal of Clinical Virology, December 2009, Elsevier

    Professor Rajiv Khanna

  33. Narrowing of T‐cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients

    Article • Immunology and Cell Biology, October 2009, Wiley

    Professor Rajiv Khanna

  34. The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length

    Article • Molecular Immunology, May 2009, Elsevier

    Professor Rajiv Khanna

  35. Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products

    Article • Seminars in Cancer Biology, December 2008, Elsevier

    Professor Rajiv Khanna

  36. Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus

    Article • PLoS ONE, September 2008, PLOS

    Professor Rajiv Khanna

  37. Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1

    Article • PLoS ONE, September 2008, PLOS

    Professor Rajiv Khanna

  38. Generating functional CD8+T cell memory response under transient CD4+T cell deficiency: Implications for vaccination of immunocompromised individuals

    Article • European Journal of Immunology, July 2008, Wiley

    Professor Rajiv Khanna

  39. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition

    Article • Molecular Immunology, March 2008, Elsevier

    Professor Rajiv Khanna

  40. Current understanding of the role of Epstein–Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas

    Article • Leukemia & Lymphoma, January 2008, Taylor & Francis

    Professor Rajiv Khanna

  41. Vaccine strategies against human cytomegalovirus infection

    Article • Expert Review of Anti-infective Therapy, June 2007, Taylor & Francis

    Professor Rajiv Khanna

  42. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV

    Article • European Journal of Immunology, April 2007, Wiley

    Professor Rajiv Khanna

  43. Nasopharyngeal carcinoma‐associated Epstein–Barr virus‐encoded oncogene latent membrane protein 1 potentiates regulatory T‐cell function

    Article • Immunology and Cell Biology, March 2007, Wiley

    Professor Rajiv Khanna

  44. Polyepitope Vaccines

    Article • March 2007, Wiley

    Professor Rajiv Khanna

  45. Epstein?Barr virus T-cell immunity despite rituximab

    Article • British Journal of Haematology, February 2007, Wiley

    Professor Rajiv Khanna

  46. Translation efficiency of EBNA1 encoded by lymphocryptoviruses influences endogenous presentation of CD8+ T cell epitopes

    Article • European Journal of Immunology, February 2007, Wiley

    Professor Rajiv Khanna

  47. Models of CMV infection

    Article • Drug Discovery Today Disease Models, March 2006, Elsevier

    Professor Rajiv Khanna

  48. Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load

    Article • The Journal of Infectious Diseases, March 2006, Oxford University Press (OUP)

    Professor Rajiv Khanna

  49. Human cytomegalovirus vaccine: time to look for alternative options

    Article • Trends in Molecular Medicine, January 2006, Elsevier

    Dr. Don J Diamond, Professor Rajiv Khanna

  50. Transduction of Primary Lymphocytes with Epstein-Barr Virus (EBV) Latent Membrane Protein-Specific T-Cell Receptor Induces Lysis of Virus-Infected Cells: A Novel Strategy for the Treatment of Hodgkin's Disease and Nasopharyngeal Carcinoma

    Article • Journal of Clinical Immunology, January 2006, Springer Science + Business Media

    Professor Rajiv Khanna

  51. Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty?

    Article • Leukemia & Lymphoma, January 2006, Taylor & Francis

    Professor Rajiv Khanna

  52. Viruses and lymphoma

    Article • Pathology, December 2005, Elsevier

    Professor Rajiv Khanna

  53. Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignancies

    Article • Nature Clinical Practice Oncology, March 2005, Springer Science + Business Media

    Professor Rajiv Khanna

  54. Ex vivoexpansion of human cytomegalovirus-specific cytotoxic T?cells by recombinant polyepitope: implications for HCMV immunotherapy

    Article • European Journal of Immunology, March 2005, Wiley

    Professor Rajiv Khanna

  55. Contemporaneous fluctuations in T?cell responses to persistent herpes virus infections

    Article • European Journal of Immunology, January 2005, Wiley

    Professor Rajiv Khanna

  56. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments

    Article • The Lancet Infectious Diseases, December 2004, Elsevier

    Professor Rajiv Khanna

  57. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T?lymphocytes specific for glycoprotein?B and?H

    Article • European Journal of Immunology, November 2004, Wiley

    Professor Rajiv Khanna

  58. Epstein-Barr virus-associated Hodgkin's lymphoma

    Article • British Journal of Haematology, March 2004, Wiley

    Professor Rajiv Khanna

  59. Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy

    Article • Transplantation, May 2003, Wolters Kluwer Health

    Professor Rajiv Khanna

  60. Role of LMP1 in immune control of EBV infection

    Article • Seminars in Cancer Biology, December 2001, Elsevier

    Professor Rajiv Khanna

  61. Immunotherapeutic strategies for EBV-associated malignancies

    Article • Trends in Molecular Medicine, June 2001, Elsevier

    Professor Rajiv Khanna

  62. Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases

    Article • Annual Review of Microbiology, October 2000, Annual Reviews

    Professor Rajiv Khanna

  63. Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation

    Article • Immunological Reviews, August 1999, Wiley

    Professor Rajiv Khanna

  64. The influence of antiviral T-cell responses on the alloreactive repertoire

    Article • Immunology Today, May 1999, Elsevier

    Professor Rajiv Khanna

  65. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction

    Article • European Journal of Immunology, May 1999, Wiley

    Professor Rajiv Khanna

  66. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction

    Article • European Journal of Immunology, May 1999, Wiley

    Professor Rajiv Khanna

  67. Major histocompatibility complex: from genes to function

    Article • Immunology Today, April 1999, Elsevier

    Professor Rajiv Khanna

  68. HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading

    Article • Immunity, May 1998, Elsevier

    Professor Rajiv Khanna

  69. Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell‐mediated immune recognition of human melanoma cells

    Article • International Journal of Cancer, February 1998, Wiley

    Professor Rajiv Khanna

  70. Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells

    Article • International Journal of Cancer, February 1998, Wiley

    Professor Rajiv Khanna

  71. Tumour surveillance: Missing peptides and MHC molecules

    Article • Immunology and Cell Biology, February 1998, Wiley

    Professor Rajiv Khanna

  72. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes

    Article • European Journal of Immunology, February 1998, Wiley

    Professor Rajiv Khanna

  73. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity

    Article • European Journal of Immunology, July 1997, Wiley

    Professor Rajiv Khanna

  74. Hierarchy of virus-specific CTL responses in individuals carrying different subtypes of a single HLA allele: influence of peptide affinity and intracellular transport of HLA molecules

    Article • Immunology Letters, May 1997, Elsevier

    Professor Rajiv Khanna

  75. Immune selection and virus evolution: Be cautious of paradigms

    Article • Trends in Microbiology, March 1997, Elsevier

    Professor Rajiv Khanna

  76. The role of cytotoxic T lymphocytes in the evolution of genetically stable viruses

    Article • Trends in Microbiology, February 1997, Elsevier

    Professor Rajiv Khanna

  77. Recruitment during Infectious Mononucleosis of CD3+CD4+CD8+Virus-Specific Cytotoxic T Cells Which Recognise Epstein–Barr Virus Lytic Antigen BHRF1

    Article • Virology, May 1996, Elsevier

    Professor Rajiv Khanna

  78. Strategies Involved in Developing an Effective Vaccine for EBV-Associated Diseases

    Article • January 1996, Elsevier

    Professor Rajiv Khanna

  79. Isolation of Cytotoxic T Lymphocytes from Healthy Seropositive Individuals Specific for Peptide Epitopes from Epstein–Barr Virus Nuclear Antigen 1: Implications for Viral Persistence and Tumor Surveillance1

    Article • Virology, December 1995, Elsevier

    Professor Rajiv Khanna

  80. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

    Article • European Journal of Immunology, May 1995, Wiley

    Professor Rajiv Khanna

  81. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population

    Article • European Journal of Immunology, January 1995, Wiley

    Professor Rajiv Khanna

  82. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line

    Article • International Immunology, January 1994, Oxford University Press (OUP)

    Professor Rajiv Khanna

  83. Systemic-oral immunization with 56 kDa molecule of Giardia lamblia affords protection in experimental mice

    Article • Vaccine, January 1992, Elsevier

    Professor Rajiv Khanna

  84. Systemic-oral immunization with 56 KDa molecule of Giardia lamblia affords protection in experimental mice

    Article • Vaccine, January 1992, Elsevier

    Professor Rajiv Khanna

  85. Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis

    Article • Springer Seminars in Immunopathology, December 1991, Springer Science + Business Media

    Professor Rajiv Khanna

  86. Systems Engineering for Large-Scale Fingerprint Systems

    Article • Springer Science + Business Media

    Professor Rajiv Khanna

  87. EBV: Immunobiology and host response

    Article • Cambridge University Press

    Professor Rajiv Khanna

  88. Epstein–Barr virus vaccines

    Article • Cambridge University Press

    Professor Rajiv Khanna